US 8765146
Adenoviral vector-based malaria vaccines
granted A61KA61K2039/5256A61K2039/53
Quick answer
US patent 8765146 (Adenoviral vector-based malaria vaccines) held by United States of America as represented by the Secretary of the Air Force expires Mon Jun 26 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- United States of America as represented by the Secretary of the Air Force
- Grant date
- Tue Jul 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 26 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K2039/5256, A61K2039/53, A61K2039/545, A61K39/015